vTv Therapeutics Inc. (VTVT) stock
VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$16.23−1.06 (-6.13%)
Close on Nov 18, 2026Market cap $64.17MP/E –Yield –
vTv Therapeutics cash
Cash and short-term investments held at the end of each period.
vTv Therapeutics's cash was $86.64M at Jun 30, 2026. For fiscal 2025 it was $88.93M, up 142.0% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $88.93M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.93M | +142.0% |
| FY2024 | Dec 31, 2024 | $36.75M | +289.0% |
| FY2023 | Dec 31, 2023 | $9.45M | -22.1% |
| FY2022 | Dec 31, 2022 | $12.13M | -9.6% |
| FY2021 | Dec 31, 2021 | $13.42M | +133.4% |
| FY2020 | Dec 31, 2020 | $5.75M | +34.4% |
| FY2019 | Dec 31, 2019 | $4.28M | +2.2% |
| FY2018 | Dec 31, 2018 | $4.18M | -71.0% |
| FY2017 | Dec 31, 2017 | $14.42M | -72.0% |
| FY2016 | Dec 31, 2016 | $51.51M | -41.5% |
| FY2015 | Dec 31, 2015 | $88.00M | +6258.6% |
| FY2014 | Dec 31, 2014 | $1.38M | +27.1% |
| FY2013 | Dec 31, 2013 | $1.09M | -48.7% |
| FY2012 | Dec 31, 2012 | $2.12M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $86.64M | +234.2% |
| Q1 FY2026 | Mar 31, 2026 | $98.09M | +215.8% |
| Q4 FY2025 | Dec 31, 2025 | $88.93M | +142.0% |
| Q3 FY2025 | Sep 30, 2025 | $98.50M | +137.0% |
| Q2 FY2025 | Jun 30, 2025 | $25.92M | -43.1% |
| Q1 FY2025 | Mar 31, 2025 | $31.06M | -40.6% |
| Q4 FY2024 | Dec 31, 2024 | $36.75M | +289.0% |
| Q3 FY2024 | Sep 30, 2024 | $41.57M | +404.6% |
| Q2 FY2024 | Jun 30, 2024 | $45.53M | +261.3% |
| Q1 FY2024 | Mar 31, 2024 | $52.26M | +178.5% |
| Q4 FY2023 | Dec 31, 2023 | $9.45M | -22.1% |
| Q3 FY2023 | Sep 30, 2023 | $8.24M | -46.3% |
| Q2 FY2023 | Jun 30, 2023 | $12.60M | -29.5% |
| Q1 FY2023 | Mar 31, 2023 | $18.77M | +54.6% |
| Q4 FY2022 | Dec 31, 2022 | $12.13M | -9.6% |
| Q3 FY2022 | Sep 30, 2022 | $15.34M | -21.6% |
| Q2 FY2022 | Jun 30, 2022 | $17.86M | +64.9% |
| Q1 FY2022 | Mar 31, 2022 | $12.14M | +43.7% |
| Q4 FY2021 | Dec 31, 2021 | $13.42M | +133.4% |
| Q3 FY2021 | Sep 30, 2021 | $19.57M | +970.9% |
| Q2 FY2021 | Jun 30, 2021 | $10.84M | +69.5% |
| Q1 FY2021 | Mar 31, 2021 | $8.45M | +190.7% |
| Q4 FY2020 | Dec 31, 2020 | $5.75M | +34.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.83M | -63.0% |
| Q2 FY2020 | Jun 30, 2020 | $6.39M | +61.3% |
| Q1 FY2020 | Mar 31, 2020 | $2.91M | -61.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.28M | +2.2% |
| Q3 FY2019 | Sep 30, 2019 | $4.94M | -21.2% |
| Q2 FY2019 | Jun 30, 2019 | $3.96M | +8.2% |
| Q1 FY2019 | Mar 31, 2019 | $7.46M | -17.4% |
| Q4 FY2018 | Dec 31, 2018 | $4.18M | -71.0% |
| Q3 FY2018 | Sep 30, 2018 | $6.27M | -69.8% |
| Q2 FY2018 | Jun 30, 2018 | $3.66M | -88.7% |
| Q1 FY2018 | Mar 31, 2018 | $9.04M | -80.0% |
| Q4 FY2017 | Dec 31, 2017 | $14.42M | -72.0% |
| Q3 FY2017 | Sep 30, 2017 | $20.77M | -59.3% |
| Q2 FY2017 | Jun 30, 2017 | $32.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $45.15M | – |
| Q4 FY2016 | Dec 31, 2016 | $51.51M | – |
| Q3 FY2016 | Sep 30, 2016 | $51.06M | – |
See a number that looks wrong?